Vaccine News and Research

Latest Vaccine News and Research

Researchers uncover new mechanism for designing antiviral drugs for dengue virus

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered a new mechanism for designing antiviral drugs for dengue virus. The study is currently available in Proceedings of the National Academy of Sciences.

14 Jul 2020

Researchers stabilize the closed SARS-CoV-2 spike trimer

Now, a new study by researchers at Janssen Vaccines & Prevention BV and Leiden University and published on the preprint server bioRxiv uses cryoEM to reveal the structure of this trimer, in order to support both vaccine development and diagnostic testing based on antibody production.

14 Jul 2020

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Now, a new study published on the preprint server medRxiv in July 2020 discusses the explanation in terms of the biological aging markers in patients with severe disease, rather than the chronological age.

13 Jul 2020

International research collaboration to investigate the role of immune system in health

An international research collaboration to pioneer the field of immuno-cardiology and investigate ways to harness the power of the immune system to improve recovery from heart attacks will be led at the Perelman School of Medicine at the University of Pennsylvania by Jonathan Epstein, MD, executive vice dean, chief scientific officer and the William Wikoff Smith Professor of Cardiovascular Research.

13 Jul 2020

Coronavirus disease immunity fades within a few months, study finds

The coronavirus disease (COVID-19) has spread rapidly across the globe, with more than 13 million people infected. Of these, an estimated 7 million have recovered from the viral infection. However, it was unclear whether being exposed to the virus would provide long-lasting immunity. Now, a new study says that SARS-CoV-2 immunity may only last for months.

13 Jul 2020

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.

13 Jul 2020

COVID-19 – researchers sum up the “Tsunami” of information

The severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection leading to COVID-19 is a raging pandemic across the world at present. It has infected 13 million and killed 571,000 individuals around the world as of today. The infection was first reported in Wuhan, Hubei Province of China in late December 2019.

13 Jul 2020

Scientists discover common molecular feature found in SARS-CoV-2 neutralizing antibodies

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

13 Jul 2020

Bat research critical to help predict and prevent the next pandemic

The current SARS-CoV-2 pandemic has a likely connection to bats, and the next viral outbreak probably will too, unless scientists can quickly learn more about the thousands of viruses carried by one of the most diverse mammals on the planet.

13 Jul 2020

NUS teams develop three nasopharyngeal swab designs for COVID-19 testing

Since the outbreak of COVID-19, there has been a global surge in demand for nasopharyngeal (NP) swabs, a key element in testing for SARS-CoV-2. Singapore is no exception. Commercially available NP swabs used in COVID-19 test kits are often out of stock due to supply chain disruptions.

13 Jul 2020

Single dose of flu drug can prevent influenza spread among household contacts

A single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households, new research concludes.

13 Jul 2020

New mutation in common subtype of influenza virus helps evade immune response

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

12 Jul 2020

FIND and Unitaid launch call for EOI to fill major diagnostic gaps in COVID-19 detection

The Foundation for Innovative New Diagnostics and Unitaid announced today that the organizations have launched a call for expressions of interest to accelerate the availability and manufacturing scale-up of rapid diagnostic tests for the detection of SARS-CoV-2 antigens. Reliable, affordable Ag RDTs have been identified as key tools in the global response to COVID-19, as they could enable robust detection of active SARS-CoV-2 infection for both patient management and contact tracing purposes in decentralized settings.

10 Jul 2020

Commentary: Children infrequently transmit Covid-19 to each other

A commentary published in the journal Pediatrics, the official peer-reviewed journal of the American Academy of Pediatrics, concludes that children infrequently transmit Covid-19 to each other or to adults and that many schools, provided they follow appropriate social distancing guidelines and take into account rates of transmission in their community, can and should reopen in the fal

10 Jul 2020

What people know and how they behave during COVID-19: Canadian perspective

Now, a new study by researchers in Canada and published on the preprint server medRxiv in July 2020 shows that national news is the primary source of information about the pandemic.

10 Jul 2020

Salmonella biofilm protein can cause autoimmune responses, arthritis in animals

Scientists from the Vaccine and Infectious Disease Organization-International Vaccine Centre at the University of Saskatchewan and Temple University have demonstrated that a Salmonella biofilm protein can cause autoimmune responses and arthritis in animals.

10 Jul 2020

Volunteers can now register for coronavirus disease vaccine trials

In an attempt to recruit many volunteers, the National Institute of Allergy and Infectious Diseases (NIAID) has established a new clinical COVID-19 Prevention Trials Network (COVPN) that aims to enroll thousands of volunteers to test various investigational vaccines against the SARS-CoV-2 infection.

10 Jul 2020

Pigs and chickens not susceptible to SARS-CoV-2

A team of researchers in Germany aimed to investigate the susceptibility of potential animal hosts and the risk of zoonosis spill-over infections, which are illnesses transmitted to humans from animals. On the other hand, reverse zoonosis pertains to infections in humans that jump to animals.

9 Jul 2020